ABSTRACT
BACKGROUND: Dilatation of the ascending aorta in aortic stenosis may be partly explained by intrinsic wall structure changes, but the relative contribution of altered hemodynamics is unclear. The aim of this study was to assess the association between ascending aortic dimensions and valve stenosis severity. METHODS AND RESULTS: An analysis of echocardiographic examinations was conducted in 296 patients with aortic stenosis (179 males, mean age 71 years), 57 with bicuspid and 239 with tricuspid aortic valve, mean transaortic gradient 43+/-20 mmHg, and not more than moderate aortic regurgitation. Aortic dimensions at the level of annulus, sinuses of Valsalva, sinotubular junction and proximal ascending aorta were measured. Only height (p<0.001), degree of aortic regurgitation (p<0.01) and presence of bicuspid aortic valve (p<0.001) were independent predictors of ascending aortic dimensions. CONCLUSIONS: An independent association between aortic pressure gradients and proximal ascending aortic dimensions was not observed in patients with bicuspid or tricuspid aortic valve stenosis. Therefore, the poststenotic dilatation of the ascending aorta is not explained by aortic stenosis severity itself. Possible nonhemodynamic causes deserve detailed study at the time of diagnosis.
Subject(s)
Aorta/pathology , Aorta/physiopathology , Aortic Valve Stenosis/pathology , Severity of Illness Index , Aged , Aortic Valve Insufficiency/physiopathology , Aortic Valve Stenosis/physiopathology , Blood Pressure , Dilatation, Pathologic/pathology , Dilatation, Pathologic/physiopathology , Echocardiography , Female , Humans , Male , Middle Aged , Mitral Valve/pathology , Mitral Valve/physiopathology , Prospective Studies , Retrospective Studies , Risk Factors , Tricuspid Valve Stenosis/pathology , Tricuspid Valve Stenosis/physiopathologyABSTRACT
The reaction of 4-substituted benzenediazonium tetrafluoroborates with 3-amino-1-phenylbut-2-en-1-one, 4-amino-4-phenylbut-3-en-2-one and their N-aryl derivatives 1a-1g has been used to prepare the respective azo coupling products i.e. compounds 2-5 from enaminone 1a, compounds 6-9 from enaminone 1c, compound 10 from enaminone 1d, compound 11 from enaminone 1e, compounds 12, 13 from enaminone 1f, compounds 14, 15 from enaminone 1b and compound 16 from enaminone 1g. Tautomerism of the azo coupling products prepared has been investigated in CDCl3 solutions by means of 1H, 13C and 15N NMR spectra. Crystal structures of selected products have also been investigated by means of X-ray diffraction.
